Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates
- 31 July 1986
- journal article
- research article
- Published by Elsevier in Molecular Brain Research
- Vol. 1 (1) , 29-35
- https://doi.org/10.1016/0169-328x(86)90017-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984
- High‐and Low‐Affinity States of Striatal D2 Receptors Are Not Affected by 6‐Hydroxydopamine or Chronic Haloperidol TreatmentJournal of Neurochemistry, 1984
- Dopaminergic 3H-agonist receptors in rat brain new evidence on localization and pharmacologyLife Sciences, 1984
- Dopaminergic D-3 binding sites are not presynaptic autoreceptorsNature, 1983
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983
- Reconstitution of catecholamine-stimulated guanosine triphosphatase activityBiochemistry, 1983
- The Classification of Dopamine Receptors: Relationship to Radioligand BindingAnnual Review of Neuroscience, 1983
- 3H-dopamine binding to rat striatal D-2 and D-3 sites: Enhancement by magnesium and inhibition by guanine nucleotides and sodiumLife Sciences, 1982
- Magnesium reduces affinities of antagonists at rat cortex α2-adrenergic receptors labeled with 3H-clonidine: Evidence for heterogeneity of α2-receptor conformations with respect to antagonistsLife Sciences, 1982
- The role of hormone receptors and GTP-regulatory proteins in membrane transductionNature, 1980